Abbott Laboratories (ABT)vsENvue Medical Inc. (FEED)
ABT
Abbott Laboratories
$104.83
+0.74%
HEALTHCARE · Cap: $180.82B
FEED
ENvue Medical Inc.
$2.26
+58.04%
HEALTHCARE · Cap: $1.31M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 1650850% more annual revenue ($44.33B vs $2.69M). ABT leads profitability with a 14.7% profit margin vs -2.5%. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
FEED
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-315.5%
Fair Value
$25.23
Current Price
$104.83
$79.60 premium
Intrinsic value data unavailable for FEED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Reasonable price relative to book value
Revenue surging 92.0% year-over-year
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -30.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : FEED
The strongest argument for FEED centers on Price/Book, Revenue Growth. Revenue growth of 92.0% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : FEED
The primary concerns for FEED are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
ABT profiles as a value stock while FEED is a hypergrowth play — different risk/reward profiles.
FEED carries more volatility with a beta of 2.28 — expect wider price swings.
FEED is growing revenue faster at 92.0% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →ENvue Medical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
ENvue Medical Inc. (FEED) is a forward-thinking healthcare technology firm committed to revolutionizing patient care management through advanced medical devices and software solutions. By harnessing innovative technology, ENvue Medical focuses on optimizing recovery processes and improving health outcomes across various clinical settings. The company's robust product pipeline, coupled with strategic collaborations, positions it well to capitalize on the growth of the healthcare industry, presenting a compelling investment opportunity for institutional investors seeking exposure to the dynamic fields of medical device innovation and digital health advancements.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?